Dogecoin Cash, Inc. (USD) Dogecoin Cash, Inc., through its various divisions, offers online telemedicine referral services, enabling clients across the United States to obtain medical marijuana cards. A central offering is PrestoDoctor, a digital healthcare platform that facilitates virtual connections between individuals and licensed physicians via video conferencing for securing medical cannabis recommendations. Beyond its telehealth operations, the company is engaged in the creation of several product lines. These encompass lozenges crafted for relief, "Recover" — a potent, deeply penetrating therapeutic balm designed to ease discomfort in sore muscles, joints, and conditions like arthritis or back pain — and "Trauma Cream," a topical solution infused with a blend of cannabinoids and THC. Furthermore, Dogecoin Cash, Inc. intends to introduce high-end men's and women's fashion from various suppliers through its e-commerce site, www.cbds.com. The firm also holds intellectual property licenses pertaining to the production of medical cannabis edibles. Its business endeavors primarily target both the cannabidiol (CBD) and broader cannabis sectors. The entity, previously known as Cannabis Sativa, Inc., adopted the name Dogecoin Cash, Inc. in November 2024 and is headquartered in Mesquite, Nevada.

Dogecoin Cash, Inc. (USD) Active

355 West Mesquite Blvd, Mesquite, NV, US, 89027

Stock Price USD

Price Change

Last Dividend USD

C+

Latest Rating

DOGP's stock peer is CMPD (CompuMed, Inc.)

DOGP's stock peer is CNGGF (Cann Group Limited)

DOGP's stock peer is HLYK (HealthLynked Corp.)

DOGP's stock peer is LLBO (Lifeline Biotechnologies, Inc.)

DOGP's stock peer is RVVTF (Revive Therapeutics Ltd.)

DOGP's stock peer is SLDX (Stella Diagnostics Inc.)

DOGP's stock peer is STHZF (StateHouse Holdings Inc.)

DOGP's stock peer is TDSGF (Telo Genomics Corp.)

DOGP's stock peer is TNRG (Thunder Energies Corporation)

Healthcare Medical - Healthcare Information Services

Dogecoin Cash, Inc., through its various divisions, offers online telemedicine referral services, enabling clients across the United States to obtain medical marijuana cards. A central offering is PrestoDoctor, a digital healthcare platform that facilitates virtual connections between individuals and licensed physicians via video conferencing for securing medical cannabis recommendations. Beyond its telehealth operations, the company is engaged in the creation of several product lines. These encompass lozenges crafted for relief, "Recover" — a potent, deeply penetrating therapeutic balm designed to ease discomfort in sore muscles, joints, and conditions like arthritis or back pain — and "Trauma Cream," a topical solution infused with a blend of cannabinoids and THC. Furthermore, Dogecoin Cash, Inc. intends to introduce high-end men's and women's fashion from various suppliers through its e-commerce site, www.cbds.com. The firm also holds intellectual property licenses pertaining to the production of medical cannabis edibles. Its business endeavors primarily target both the cannabidiol (CBD) and broader cannabis sectors. The entity, previously known as Cannabis Sativa, Inc., adopted the name Dogecoin Cash, Inc. in November 2024 and is headquartered in Mesquite, Nevada.

20%

Dcf Rating

100%

Return On Equity

20%

Return On Assets

20%

Debt To Equity

60%

Price To Earnings

20%

Price To Book

Income Statement

Dividend Stats Yield is calculated via trailing-12-month period

Ex-Dividend	Payment Date	Dividend	Yield	Dividend Frequency
Dividend Data Not Exist

Recent News

DOGECOIN CASH FILES UTILITY PATENT FOR BLOCKCHAIN INFRASTRUCTURE DESIGNED TO SUPPORT DOGECOIN APPLICATION USABILITY

Dogecoin Cash, Inc.(DOGP) files U.S. utility patent for blockchain infrastructure enabling fast Dogecoin confirmations and simplified dApp deployment.

2026-06-15 05:20:00

Dogecoin Cash, Inc. Highlights Telehealth Platform Strategy Following Federal Actions Relating to Marijuana Reclassification

Mesquite, NV, April 24, 2026 (GLOBE NEWSWIRE) -- Mesquite, Nevada - Dogecoin Cash, Inc. (OTCQB: DOGP) (“DOGP” or the “Company”) today highlighted its telehealth platform strategy through its majority ownership of PrestoDoctor, following recent federal actions relating to the reclassification of certain marijuana-related products under U.S. law. These actions include placing certain marijuana products, including those regulated under state medical cannabis licensing frameworks, within Schedule III under the Controlled Substances Act, while broader reclassification remains subject to ongoing administrative review and rulemaking.

2026-04-24 07:15:00

Disclaimers

StockQuay.com is not operated by a broker, dealer, or registered investment advisor. Under no circumstances should any information published on StockQuay.com be considered a recommendation to buy, sell, or hold any security. The content on this site and in its associated newsletters is intended solely for informational and educational purposes and does not constitute investment advice or financial recommendations.

Individuals or entities featured or referenced on StockQuay.com may engage in trading activity involving the securities mentioned in any article or report before or after such content is published. These individuals or entities are not affiliated with StockQuay.com, and their inclusion does not imply endorsement or accuracy of their views or actions.

StockQuay.com, its owners, or its affiliates shall not be held liable to any user or third party for any damages or losses arising from the use of content on this website. This includes, but is not limited to, investment losses, loss of profit, loss of data, missed opportunities, or indirect, incidental, or consequential damages.

Data is updated daily and is not guaranteed to be accurate or complete.

Past performance is not indicative of future results. Please conduct your own research or consult with a qualified financial advisor before making any investment decisions